Pagas, Cyril .
HRN: 22-17-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2022
CLINDAMYCIN 300MG (CAP)
11/07/2022
11/14/2022
PO
300mg
BID
Infected Wound 3rd Digit Right Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes